These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32039688)

  • 21. DNA nanoparticles for ophthalmic drug delivery.
    Willem de Vries J; Schnichels S; Hurst J; Strudel L; Gruszka A; Kwak M; Bartz-Schmidt KU; Spitzer MS; Herrmann A
    Biomaterials; 2018 Mar; 157():98-106. PubMed ID: 29258013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ophthalmic drug delivery systems--recent advances.
    Bourlais CL; Acar L; Zia H; Sado PA; Needham T; Leverge R
    Prog Retin Eye Res; 1998 Jan; 17(1):33-58. PubMed ID: 9537794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evolving role of genetics in ophthalmology.
    Couser NL; Brooks BP; Drack AV; Shankar SP
    Ophthalmic Genet; 2021 Apr; 42(2):110-113. PubMed ID: 33432855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ophthalmic disease of fish.
    Jurk I
    Vet Clin North Am Exot Anim Pract; 2002 May; 5(2):243-60, v. PubMed ID: 12170631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.
    López-Cano JJ; González-Cela-Casamayor MA; Andrés-Guerrero V; Herrero-Vanrell R; Molina-Martínez IT
    Expert Opin Drug Deliv; 2021 Jul; 18(7):819-847. PubMed ID: 33412914
    [No Abstract]   [Full Text] [Related]  

  • 27. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
    Fangueiro JF; Veiga F; Silva AM; Souto EB
    Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuro-ophthalmology and Pregnancy.
    Moss HE
    Continuum (Minneap Minn); 2022 Feb; 28(1):147-161. PubMed ID: 35133315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Ocular Drug Delivery Systems: An Update on Microemulsions.
    Üstündağ Okur N; Çağlar EŞ; Siafaka PI
    J Ocul Pharmacol Ther; 2020; 36(6):342-354. PubMed ID: 32255728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulus-Responsive Hydrogel for Ophthalmic Drug Delivery.
    Lin D; Lei L; Shi S; Li X
    Macromol Biosci; 2019 Jun; 19(6):e1900001. PubMed ID: 31026123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic applications of ultrasound in ophthalmology.
    Aptel F; Lafon C
    Int J Hyperthermia; 2012; 28(4):405-18. PubMed ID: 22621741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inpatient Ophthalmology Consultations.
    Grewal DS; Gabr H
    Med Clin North Am; 2021 May; 105(3):563-576. PubMed ID: 33926647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The general situation of the development of ophthalmology in recent five years in China].
    Zhao JL
    Zhonghua Yan Ke Za Zhi; 2005 Aug; 41(8):688-91. PubMed ID: 16191322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ophthalmology training and competency levels in care of patients with ophthalmic complaints in United States internal medicine, emergency medicine and family medicine residents.
    Gelston CD; Patnaik JL
    J Educ Eval Health Prof; 2019; 16():25. PubMed ID: 31461804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Experience with Technology-Based Eye Care Services (TECS): A Novel Ophthalmologic Telemedicine Initiative.
    Maa AY; Wojciechowski B; Hunt KJ; Dismuke C; Shyu J; Janjua R; Lu X; Medert CM; Lynch MG
    Ophthalmology; 2017 Apr; 124(4):539-546. PubMed ID: 28081944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview.
    Almeida H; Amaral MH; Lobão P; Sousa Lobo JM
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1223-37. PubMed ID: 23688342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanocarriers in ocular drug delivery: an update review.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applications of nanoparticles in ophthalmology.
    Diebold Y; Calonge M
    Prog Retin Eye Res; 2010 Nov; 29(6):596-609. PubMed ID: 20826225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of an Ophthalmic Hospital-Based Virtual Service during the COVID-19 Pandemic.
    Wu X; Chen J; Yun D; Yuan M; Liu Z; Yan P; Sim DA; Zhu Y; Chen C; Hu W; Wu Z; Lin H; Wang Y; Wu Y; Chen M; Zhang C; Zheng Y; Liu X; Zhong X; Diao H; Wei Ting DS; Gunasekeran DV; Li Y; Zhang J; Cai Y; Lao Z; Liu Y; Wong TY; Lin X; Lin H
    Ophthalmology; 2021 Jun; 128(6):942-945. PubMed ID: 33069751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.